Convalescent Plasma Therapy Global Market Report 2024 - By Share, Growth, Demand, Trends, Forecast To 2033

Global convalescent plasma therapy market size is expected to reach $0.08 Bn by 2028 at a rate of 12.8 % segmented as by antibody type, igm, igg, iga

Share this Post to earn Money ( Upto ₹100 per 1000 Views )


Convalescent Plasma Therapy Global Market Report 2024 - By Share, Growth, Demand, Trends, Forecast To 2033
Convalescent Plasma Therapy Global Market

The convalescent plasma therapy market size is expected to see rapid growth in the next few years. It will grow to " $0.08 billion in 2028 at a compound annual growth rate (CAGR) of 12.8%.  The growth in the forecast period can be attributed to evolving pathogens, immunotherapies development, regulatory frameworks, global preparedness, public health initiatives. Major trends in the forecast period include standardized collection and processing, targeted plasma components, personalized treatment, telemedicine and remote monitoring, research into long-term effects.

Order your report now for swift delivery @
https://www.thebusinessresearchcompany.com/report/convalescent-plasma-therapy-global-market-report

Scope Of Convalescent Plasma Therapy Market
The Business Research Company's reports encompass a wide range of information, including:

1. Market Size (Historic and Forecast): Analysis of the market's historical performance and projections for future growth.
2. Drivers: Examination of the key factors propelling market growth.
3. Trends: Identification of emerging trends and patterns shaping the market landscape.
4. Key Segments: Breakdown of the market into its primary segments and their respective performance.
5. Focus Regions and Geographies: Insight into the most critical regions and geographical areas influencing the market.
6. Macro Economic Factors: Assessment of broader economic elements impacting the market.

Convalescent Plasma Therapy Market Overview

Market Drivers -
Higher efficacy and safety evaluated during the trials conducted for CPT in COVID-19 patients can drive the market growth during the forecast period. Convalescent plasma transfusion has been of interest in the historical period for the treatment of other infectious disease outbreaks such as SARS‐1, Middle East Respiratory Syndrome (MERS), and 2009 H1N1. In June 2020, results of a study conducted by the Houston Methodist hospital, which aimed at evaluating safety and efficacy of COVID-19 convalescent plasma therapy, stated that the convalescent plasma therapy is safe with no adverse events reported and is efficient with 76% recovery rate. In May 2020, a study published in the Journal of Medical Virology stated that with convalescent plasma therapy, the mortality rate may be reduced in critically ill patients, beneficial effects on clinical symptoms will be observed, and an increase in neutralizing antibody titers and disappearance of SARS‐CoV‐2 RNA will be observed. The safety and efficacy of the convalescent plasma therapy in COVID-19 patients will boost the global convalescent plasma therapy market growth.

The convalescent plasma therapy market covered in this report is segmented –
1) By Antibody type: IgM, IgG, IgA
2) By Application: Prophylaxis, Treatment
3) By End-Users: Hospitals & Clinics, Laboratories & Research institutes

Get an inside scoop of the convalescent plasma therapy market, Request now for Sample Report @
https://www.thebusinessresearchcompany.com/sample.aspx?id=3233&type=smp

Regional Insights -
North America was the largest region in the convalescent plasma therapy market in 2023. Western Europe was the second largest region in the convalescent plasma therapy market. The regions covered in the convalescent plasma therapy market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa

Key Companies -
Major companies operating in the convalescent plasma therapy market include Bio Farma, Hilton Pharma Ltd., Biotest AG, BPL Ltd., LFB SA, Octapharma AG, CSL Behring LLC, Takeda Pharmaceutical Company Ltd., Orthosera Kft., ADMA Biologics Inc., GC Biopharma Corp, Grifols S.A, Sanquin Plasma Products B.V., America's Blood Centers, Blood Centers of America Inc., Anthem Inc., Laboratory Corporation of America Holdings, Cerus Corporation, Emergent BioSolutions Inc., Kedrion Biopharma Inc., New York Blood Center, Blood Systems Inc., OneBlood Inc., Gulf Coast Regional Blood Center, Bloodworks Northwest, Blood Assurance Inc., New York Blood Center Inc., Honolulu Blood-Plasma Bank, Community Blood Center, LifeStream Blood Bank

Table of Contents
1. Executive Summary
2. Convalescent Plasma Therapy Market Report Structure
3. Convalescent Plasma Therapy Market Trends And Strategies
4. Convalescent Plasma Therapy Market – Macro Economic Scenario
5. Convalescent Plasma Therapy Market Size And Growth
…..
27. Convalescent Plasma Therapy Market Competitor Landscape And Company Profiles
28. Key Mergers And Acquisitions
29. Future Outlook and Potential Analysis
30. Appendix

Read Related Topics:
https://goodprnews.com/3d-medical-imaging-devices-global-market-size/
https://goodprnews.com/amplifiers-global-market-size/
https://goodprnews.com/armored-vehicles-global-market-growth/
https://topprnews.com/3d-medical-imaging-devices-global-market-share/
https://topprnews.com/amplifiers-global-market-share/
https://topprnews.com/armored-vehicles-global-market-size/

Contact Us:
The Business Research Company
Europe: +44 207 1930 708
Asia: +91 88972 63534
Americas: +1 315 623 0293
Email: info@tbrc.info

Follow Us On:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
Twitter: https://twitter.com/tbrc_info
Facebook: https://www.facebook.com/TheBusinessResearchCompany
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Blog: https://blog.tbrc.info/
Healthcare Blog: https://healthcareresearchreports.com/
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model